SPECC1L: a cytoskeletal protein that regulates embryonic tissue dynamics
Biochemical Society Transactions · 2023
DOI: 10.1042/bst20220461 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Society Transactions, 2023. Verfasst von Irfan Saadi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS, U.S.A. Hauptthemen laut MEDLINE: Actins, Actomyosin. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIDCR NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
Many structural birth defects occur due to failure of tissue movement and fusion events during embryogenesis. Examples of such birth defects include failure of closure of the neural tube, palate, and ventral body wall. Actomyosin forces play a pivotal role in these closure processes, making proteins that regulate actomyosin dynamics a priority when studying the etiology of structural birth defects. SPECC1L (sperm antigen with calponin homology and coiled-coil domains 1 like) cytoskeletal protein associates with microtubules, filamentous actin, non-muscle myosin II (NMII), as well as membrane-associated components of adherens junctions. Patients with SPECC1L mutations show a range of structural birth defects affecting craniofacial development (hypertelorism, cleft palate), ventral body wall (omphalocele), and internal organs (diaphragmatic hernia, bicornuate uterus). Characterization of mouse models indicates that these syndromic mutations utilize a gain-of-function mechanism to affect intra- and supra-cellular actin organization. Interestingly, SPECC1L deficiency appears to affect the efficiency of tissue dynamics, making it an important cytoskeletal regulator to study tissue movement and fusion events during embryonic development. Here we summarize the SPECC1L-related syndrome mutations, phenotypes of Specc1l mouse models, and cellular functions of SPECC1L that highlight how it may regulate embryonic tissue dynamics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS, U.S.A.
- Institute for Reproductive and Developmental Sciences, University of Kansas Medical Center, Kansas City, KS, U.S.A.
- Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, KS, U.S.A.
ORCID-Profile: Irfan Saadi, Brittany M Hufft-Martinez, Pamela V Tran
Förderung
- NIGMS NIH HHS
- NIDCR NIH HHS
- NICHD NIH HHS
Zitieren
APA
Saadi, I., Goering, J. P., Hufft-Martinez, B. M., & Tran, P. V. (2023). SPECC1L: a cytoskeletal protein that regulates embryonic tissue dynamics. Biochemical Society Transactions. https://doi.org/10.1042/bst20220461
Vancouver
Saadi I, Goering JP, Hufft-Martinez BM, Tran PV. SPECC1L: a cytoskeletal protein that regulates embryonic tissue dynamics. Biochemical Society Transactions. 2023. doi:10.1042/bst20220461
BibTeX
@article{Saadi2023,
author = {Saadi, Irfan and Goering, Jeremy P and Hufft-Martinez, Brittany M and Tran, Pamela V},
title = {SPECC1L: a cytoskeletal protein that regulates embryonic tissue dynamics},
journal = {Biochemical Society Transactions},
year = {2023},
doi = {10.1042/bst20220461}
}
EUVIMED